Overview of Diabetes Assays Market: Size, Trends, Share and Growth Forecast till 2023

Latest Report Available at Analytical Research Cognizance Diabetes Assays Market provide pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.

Summary
“Diabetes Assays – Medical Devices Pipeline Assessment, 2018″ provides an overview of Diabetes Assays currently in pipeline stage.The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Diabetes Assays pipeline products.

Browse the full report @ http://www.arcognizance.com/report/diabetes-assays-medical-devices-pipeline-assessment-2018

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
– Extensive coverage of the Diabetes Assays under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Diabetes Assays and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry.

Reasons to buy
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Diabetes Assays under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date.

Request a sample of this report @ http://www.arcognizance.com/enquiry-sample/99146

Companies Mentioned:
Abcodia Ltd
Abionic SA
Achira Labs Pvt Ltd
Adaptive Biotechnologies Corp
Alfa Wassermann Inc
Aura Biotechnologies Pvt Ltd
Beckman Coulter Inc
Biocrates Life Sciences AG
Caprion Biosciences Inc
Drexel University
ELITechGroup Inc
Enable Biosciences Inc
Fujirebio Diagnostics Inc
Genalyte Inc
Helmholtz Centre for Infection Research
ImmusanT Inc
Janssen Pharmaceuticals Inc
Johns Hopkins University
Mellitus, LLC
Mindray Medical International Ltd
Numares AG
Ortho-Clinical Diagnostics Inc
PeriRx Inc
PortaScience Inc
Protagen AG
Queen Mary University of London
QuickCheck Health Inc
Singulex Inc
The Forsyth Institute
University of Canterbury
University of Colorado
University of Florida
University of South Florida
Xhale Inc
Yaathum Biotech Pvt Ltd

Purchase copy of this Report @ http://www.arcognizance.com/purchase/99146

Some Points from Toc:

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6

2 Introduction 7
2.1 Diabetes Assays Overview 7

3 Products under Development 8
3.1 Diabetes Assays – Pipeline Products by Stage of Development 8
3.2 Diabetes Assays – Pipeline Products by Segment 9
3.3 Diabetes Assays – Pipeline Products by Territory 10
3.4 Diabetes Assays – Pipeline Products by Regulatory Path 11
3.5 Diabetes Assays – Pipeline Products by Estimated Approval Date 12

4 Diabetes Assays – Pipeline Products under Development by Companies 13
4.1 Diabetes Assays Companies – Pipeline Products by Stage of Development 13
4.2 Diabetes Assays – Pipeline Products by Stage of Development 15

5 Diabetes Assays Companies and Product Overview 17
5.1 Abcodia Ltd Company Overview 17
5.2 Abionic SA Company Overview 18
5.3 Achira Labs Pvt Ltd Company Overview 19
5.4 Adaptive Biotechnologies Corp Company Overview 20
5.5 Alfa Wassermann Inc Company Overview 21
5.6 Aura Biotechnologies Pvt Ltd Company Overview 22
5.7 Beckman Coulter Inc Company Overview 24
5.8 Biocrates Life Sciences AG Company Overview 29
5.9 Caprion Biosciences Inc Company Overview 31
5.10 Drexel University Company Overview 33
5.11 ELITechGroup Inc Company Overview 34
5.12 Enable Biosciences Inc Company Overview 36
5.13 Fujirebio Diagnostics Inc Company Overview 37
5.14 Genalyte Inc Company Overview 38
5.15 Helmholtz Centre for Infection Research Company Overview 39
5.16 ImmusanT Inc Company Overview 40
5.17 Janssen Pharmaceuticals Inc Company Overview 41
5.18 Johns Hopkins University Company Overview 42
5.19 Mellitus, LLC Company Overview 43
5.20 Mindray Medical International Ltd Company Overview 44
5.21 Numares AG Company Overview 46
5.22 Ortho-Clinical Diagnostics Inc Company Overview 47
5.23 PeriRx Inc Company Overview 52
5.24 PortaScience Inc Company Overview 53
5.25 Protagen AG Company Overview 54
5.26 Queen Mary University of London Company Overview 55
5.27 QuickCheck Health Inc Company Overview 56
5.28 Singulex Inc Company Overview 57
5.29 The Forsyth Institute Company Overview 58
5.30 University of Canterbury Company Overview 59
5.31 University of Colorado Company Overview 60
5.32 University of Florida Company Overview 62
5.33 University of South Florida Company Overview 63
5.34 Xhale Inc Company Overview 64
5.35 Yaathum Biotech Pvt Ltd Company Overview 65

6 Diabetes Assays- Recent Developments 66
6.1 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 66
6.2 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future 67
6.3 Jan 25, 2018: Proteomics International Laboratories: Quarterly Business Update 67
6.4 Nov 22, 2017: Proteomics International strengthens Board and Business Development team 69
6.5 Oct 20, 2017: Asahi Kasei Pharma received 510(k) clearance from the FDA for Lucica Glycated Albumin-L 70
6.6 Oct 05, 2017: Mercodia Akurio Multiplex Used in a Recently Published Article 71
6.7 Aug 29, 2017: New technology could predict the risk of type 2 diabetes 71
6.8 Aug 16, 2017: HealPros and BioIQ Collaborate to Deliver a Comprehensive Diabetes Care Gap Closure Solution to Help Health Plans Improve Quality Ratings 72
6.9 Jul 18, 2017: Australian-first at-home blood test helping researchers delay and prevent onset of type 2 diabetes 73
6.10 Jul 18, 2017: Oramed Pharmaceuticals appoints vice president of medical affairs 74
6.11 Jul 17, 2017: EKF publish new diabetes and HbA1c testing guide 74

About US:

 www.arcognizance.com  is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics” based on the data collection facilities of big data, the face of “business research facilities” has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the “out of the box” developments in the market.

Contact US:

Name: Analytical research cognizance

Address:  100 Church Street,

8th floor, Manhattan,

New York 10007

Phone: +1 (646) 434-7969   +91 90967 44448

Email: enquiry@arcognizance.com

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *